Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 73

1.

Twin epidemics of new and prevalent hepatitis C infections in Canada: BC Hepatitis Testers Cohort.

Janjua NZ, Yu A, Kuo M, Alvarez M, Cook D, Wong J, Tyndall MW, Krajden M.

BMC Infect Dis. 2016 Jul 19;16:334. doi: 10.1186/s12879-016-1683-z.

2.

Towards safe injection practices for prevention of hepatitis C transmission in South Asia: Challenges and progress.

Janjua NZ, Butt ZA, Mahmood B, Altaf A.

World J Gastroenterol. 2016 Jul 7;22(25):5837-52. doi: 10.3748/wjg.v22.i25.5837.

3.

Assessing Hepatitis C Burden and Treatment Effectiveness through the British Columbia Hepatitis Testers Cohort (BC-HTC): Design and Characteristics of Linked and Unlinked Participants.

Janjua NZ, Kuo M, Chong M, Yu A, Alvarez M, Cook D, Armour R, Aiken C, Li K, Mussavi Rizi SA, Woods R, Godfrey D, Wong J, Gilbert M, Tyndall MW, Krajden M.

PLoS One. 2016 Mar 8;11(3):e0150176. doi: 10.1371/journal.pone.0150176. eCollection 2016.

4.

Barriers and Facilitators of Compliance with Universal Precautions at First Level Health Facilities in Northern Rural Pakistan.

Yousafzai MT, Janjua NZ, Siddiqui AR, Rozi S.

Int J Health Sci (Qassim). 2015 Oct;9(4):388-99.

5.

Decreasing Hepatitis C Incidence Among a Population With Repeated Tests: British Columbia, Canada, 1993-2011.

Kuo M, Janjua NZ, Burchell AN, Buxton JA, Krajden M, Gilbert M.

Am J Public Health. 2015 Aug;105(8):1604-10. doi: 10.2105/AJPH.2015.302591. Epub 2015 Jun 11.

PMID:
26066920
6.

Association of household and community socioeconomic position and urbanicity with underweight and overweight among women in Pakistan.

Janjua NZ, Mahmood B, Bhatti JA, Khan MI.

PLoS One. 2015 Apr 2;10(4):e0122314. doi: 10.1371/journal.pone.0122314. eCollection 2015.

7.

Sexually transmitted infection trends among gay or bisexual men from a clinic-based sentinel surveillance system in British Columbia, Canada.

Ling DI, Janjua NZ, Wong S, Krajden M, Hoang L, Morshed M, Achen M, Murti M, Lester RT, Wong J, Ogilvie G, Gilbert M.

Sex Transm Dis. 2015 Mar;42(3):153-9. doi: 10.1097/OLQ.0000000000000250.

PMID:
25668648
8.

Differentiation of acute from chronic hepatitis C virus infection by nonstructural 5B deep sequencing: a population-level tool for incidence estimation.

Montoya V, Olmstead AD, Janjua NZ, Tang P, Grebely J, Cook D, Richard Harrigan P, Krajden M.

Hepatology. 2015 Jun;61(6):1842-50. doi: 10.1002/hep.27734. Epub 2015 Mar 18.

PMID:
25645961
9.

Reporting the results of a controlled trial.

Janjua NZ, Bhatti JA, Rizwan F.

J Pak Med Assoc. 2014 Aug;64(8):970-3. No abstract available.

10.

Writing the introduction and methods of a controlled trial.

Bhatti JA, Janjua NZ, Akhtar U, Azad A.

J Pak Med Assoc. 2014 Jun;64(6):720-2. No abstract available.

11.

Trends in mortality after diagnosis of hepatitis C virus infection: an international comparison and implications for monitoring the population impact of treatment.

Aspinall EJ, Hutchinson SJ, Janjua NZ, Grebely J, Yu A, Alavi M, Amin J, Goldberg DJ, Innes H, Law M, Walter SR, Krajden M, Dore GJ.

J Hepatol. 2015 Feb;62(2):269-77. doi: 10.1016/j.jhep.2014.09.001. Epub 2014 Sep 6.

PMID:
25200903
12.

Pre- and postpandemic estimates of 2009 pandemic influenza A(H1N1) seroprotection to inform surveillance-based incidence, by age, during the 2013-2014 epidemic in Canada.

Skowronski DM, Chambers C, Sabaiduc S, Janjua NZ, Li G, Petric M, Krajden M, Purych D, Li Y, De Serres G.

J Infect Dis. 2015 Jan 1;211(1):109-14. doi: 10.1093/infdis/jiu366. Epub 2014 Jun 27.

13.

Does knowledge about bloodborne pathogens influence the reuse of medical injection syringes among women in Pakistan?

Janjua NZ, Mahmood B, Imran Khan M.

J Infect Public Health. 2014 Jul-Aug;7(4):345-55. doi: 10.1016/j.jiph.2014.04.001. Epub 2014 May 23.

PMID:
24861642
14.

Low 2012-13 influenza vaccine effectiveness associated with mutation in the egg-adapted H3N2 vaccine strain not antigenic drift in circulating viruses.

Skowronski DM, Janjua NZ, De Serres G, Sabaiduc S, Eshaghi A, Dickinson JA, Fonseca K, Winter AL, Gubbay JB, Krajden M, Petric M, Charest H, Bastien N, Kwindt TL, Mahmud SM, Van Caeseele P, Li Y.

PLoS One. 2014 Mar 25;9(3):e92153. doi: 10.1371/journal.pone.0092153. eCollection 2014.

15.

Randomized controlled ferret study to assess the direct impact of 2008-09 trivalent inactivated influenza vaccine on A(H1N1)pdm09 disease risk.

Skowronski DM, Hamelin ME, De Serres G, Janjua NZ, Li G, Sabaiduc S, Bouhy X, Couture C, Leung A, Kobasa D, Embury-Hyatt C, de Bruin E, Balshaw R, Lavigne S, Petric M, Koopmans M, Boivin G.

PLoS One. 2014 Jan 27;9(1):e86555. doi: 10.1371/journal.pone.0086555. eCollection 2014.

16.

Influenza A/subtype and B/lineage effectiveness estimates for the 2011-2012 trivalent vaccine: cross-season and cross-lineage protection with unchanged vaccine.

Skowronski DM, Janjua NZ, Sabaiduc S, De Serres G, Winter AL, Gubbay JB, Dickinson JA, Fonseca K, Charest H, Bastien N, Li Y, Kwindt TL, Mahmud SM, Van Caeseele P, Krajden M, Petric M.

J Infect Dis. 2014 Jul 1;210(1):126-37. Epub 2014 Jan 19.

17.

Presenting budget in a research grant application.

Bhatti JA, Akhtar U, Butt BA, Janjua NZ.

J Pak Med Assoc. 2013 Jun;63(6):793-6. Review. No abstract available.

18.

Virus-host interactions and the unusual age and sex distribution of human cases of influenza A(H7N9) in China, April 2013.

Skowronski DM, Janjua NZ, Kwindt TL, De Serres G.

Euro Surveill. 2013 Apr 25;18(17):20465. No abstract available.

19.

Understanding suboptimal influenza vaccine effectiveness within the agent, host, and environment paradigm.

Skowronski DM, Janjua NZ, De Serres G.

Clin Infect Dis. 2013 Aug;57(3):476-7. doi: 10.1093/cid/cit256. Epub 2013 Apr 25. No abstract available.

20.

Re: "effectiveness of adjuvanted influenza vaccination in elderly subjects in northern Italy".

Skowronski DM, De Serres G, Janjua NZ, Hottes TS.

Am J Epidemiol. 2013 Mar 15;177(6):593-4. doi: 10.1093/aje/kwt021. Epub 2013 Feb 22. No abstract available.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk